Health Canada Approves Two BCR-ABL Tests

Sep

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care.

Oct

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

Menu

Health Canada Approves Two BCR-ABL Tests

To read the full story....

Breaking News

JP Morgan Downgrades Illumina to Neutral on Grail Deal

Ortho Clinical Diagnostics Nabs $12.9M BARDA Award for SARS-CoV-2 Antigen, Antibody Tests

Arna Genomics Raises $3.5M In Series A Financing

Biocept Lung Cancer Liquid Biopsy Test Obtains Coverage From Blue Cross Affiliate Highmark

Illumina to Acquire Grail for $8B in Cash and Stock

Scanwell Health Receives $1.6M NIH Grant to Develop At-Home Test for Chronic Kidney Disease

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

What's Popular?

FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

Illumina to Acquire Grail for $8B in Cash and Stock

CDC Reverses Position, Says Asymptomatic Patients Should Be Tested for SARS-CoV-2

FDA Publishes First Batch of SARS-CoV-2 MDx Limit of Detection Comparison Results

FDA Grants Emergency Use Authorization to Coronavirus Tests From Visby Medical, SNIBE

Sponsorships